EP3370775
COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.11.2016:
19.4.2023:
16805576.2
:
2.11.2036
:
COMBINATION OF BCL-2 INHIBITOR AND MEK INHIBITOR FOR THE TREATMENT OF CANCER
3.11.2016
19.4.2023
:
Genentech, Inc.:
1 DNA Way, South San Francisco, CA 94080, US
:
Board of Regents, The University of Texas System:
201 West 7th Street, Austin, TX 78701, US
:
MERCHANT, Mark:
South San Francisco, California 94080, US
:
SAMPATH, Deepak:
South San Francisco, California 94080, US
:
KONOPLEVA, Marina Yurievna:
Houston, Texas 77030, US
:
HAN, Lina:
Houston, Texas 77030, US
:
201562250231 P:
3.11.2015:
US
:
201562263082 P:
4.12.2015:
US
:
US2016060271:
3.11.2016
:
A61K 31/4523, A61K 31/496, A61P 35/00, A61P 35/02